<DOC>
	<DOC>NCT01225315</DOC>
	<brief_summary>This study will assess the efficacy and safety of ACT-129968 in subjects with partly controlled asthma on reliever therapy only.</brief_summary>
	<brief_title>Study of ACT-129968 in Adult Patients With Partly Controlled Asthma.</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Males and females age 18 to 65 years Presenting with a diagnosis of asthma according to GINA Guidelines Prebronchodilator forced expiratory volume in one second (FEV1) &lt; / = 85% of patient's predicted normal value Reversibility of airway obstruction of &gt; / = 12% and &gt; / = 200mL from prebronchodilator FEV1 ACQ score &gt; / = 1.5 History of lifethreatening asthma Any asthma exacerbation requiring treatment with systemic corticosteroids within the last 3 months Ongoing or recent treatment with medication for allergic airway disease Smoking within the last year, or lifetime consumption &gt; / = 10 packyears (e.g., 20 cigarettes/day for 10 years) History of chronic pulmonary disease (other than asthma), such as chronic obstructive pulmonary disease (COPD), fibrosis, tuberculosis or sarcoidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>